Missing 3rd finger of T.Rex’s undersized hands discovered

Washington, Oct 18 : Palaeontologists have, after decades of searching, finally found the missing third finger of one of T.Rex’s undersized hands.

Mylan, Reliance, Ranbaxy In Shasun’s Bulk Drug Unit Battle

Mumbai: A recent report has discovered that US-based Mylan Inc, Mukesh Ambani’s Reliance Pharmaceuticals and Ranbaxy Laboratories

Princess Diana poised to announce pregnancy the night she died?

London, Oct 18 : Princess Diana was rumoured to be on the verge of announcing a pregnancy or an engagement to beau Dodi Al Fayed on the day she died, the inquest into her death has heard.

Infotech Quarterly Income Up On Strong Biz Efforts

Neyveli Lignite Is A Good Investment At The Moment

Phase II map of human genetic variation issued

Pages

News in Focus

Blue Dart Express Share Price Target at Rs 6,100: Motilal Oswal Research

Motilal Oswal has reiterated a BUY rating on Blue Dart Express with a target price of Rs 6,100, implying 15% upside from the current market price of Rs 5,284.

FDA Commissioner Tukaram Mundhe: The Man Behind the Regulatory Crackdown Reshaping India's Dairy and Food Service Industry

Maharashtra has become the first Indian state to formally outlaw analogue paneer, a non-dairy imitation product linked to health complaints, in a sweeping one-year ban announced by Food and Drugs A

Cummins India Share Price Target at Rs 6,500: Motilal Oswal Financial Services

Motilal Oswal Financial Services has reiterated a Buy rating on Cummins India, trimming its target price slightly to Rs 6,500 from Rs 6,600, still implying 20% upside from the current market price

Godrej Agrovet Share Price Target at Rs 675: Motilal Oswal Financial Services

Motilal Oswal Financial Services has reiterated a Buy rating on Godrej Agrovet, holding its target price at Rs 675, implying 24% upside from the current market price of Rs 545.

Biocon Share Price Target at Rs 520: Motilal Oswal

Motilal Oswal reiterated a "Buy" rating for Biocon with a price target of Rs520. The target has been revised but positive view on the stock remains intact.